Characterization of different functionalized lipidic nanocapsules as potential drug carriers

International Journal of Molecular Sciences

Volumn 13, Issue 2, 2012, Pages 2405-2424

  Sánchez Moreno, Paola ^a   Ortega Vinuesa, Juan Luis ^a   Martín Rodríguez, Antonio ^a   Boulaiz, Houría ^a   Marchal Corrales, Juan Antonio ^a   Peula García, José Manuel ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Drug delivery; Immuno nanocapsules; Lipid nanocapsules; Nanocarriers

Indexed keywords

C REACTIVE PROTEIN; CHITOSAN; IMMUNOGLOBULIN G ANTIBODY; LIPID NANOCAPSULE; NANOCAPSULE; NANOCARRIER; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; POLOXAMER; UNCLASSIFIED DRUG; C-REACTIVE PROTEIN; DRUG CARRIERS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; LIPIDS; NANOCAPSULES; NILE RED; OXAZINES;

ANTIGEN BINDING; ARTICLE; BIOCOMPATIBILITY; CANCER CELL CULTURE; CARCINOMA CELL; CELL TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; COVALENT BOND; DRUG DELIVERY SYSTEM; HUMORAL IMMUNITY; HYDROPHILICITY; IN VITRO STUDY; MOLECULAR STABILITY; NANOANALYSIS; NANOFABRICATION; NANOPHARMACEUTICS; PARTICLE SIZE; PHYSICAL CHEMISTRY; QUANTITATIVE STUDY; STRUCTURE ANALYSIS; SURFACE PROPERTY; CHEMICAL SYNTHESIS; CHEMISTRY; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; IMMUNOLOGY; MCF-7 CELLS; METHODS; SURFACE PROPERTIES;

C-REACTIVE PROTEIN; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; HUMANS; IMMUNOCONJUGATES; IMMUNOGLOBULIN G; LIPIDS; MCF-7 CELLS; NANOCAPSULES; OXAZINES; SURFACE PROPERTIES;

EID: 84857670706     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13022405     Document Type: Article

References (54)

1. Duncan, R. Nanomedicines in action. Pharm. J. 2004, 273, 485-488.
2. Royal Society & Royal Academy of Engineering. Nanoscience and Nanotechnologies: Opportunities and Uncertainties; Royal Society: London, UK, 2004.
3. European Science Foundation. Nanomedicine. An ESF-European Medical Research Councils (EMRC) Forward Look Report; European Science Foundation: Strasbourg, France, 2005.
4. Kateb, B.; Chiu, K.; Black, K.L.; Yamamoto, V.; Khalsa, B.; Ljubimova, J.Y.; Ding, H.; Patil, R.; Portilla-Arias, J.A.; Modo, M. et al. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: What should be the policy? NeuroImage 2011, 54, 106-124.
5. Malan, Y.; Loizidou, M.; Seifalian, A.M. Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci. 2009, 30, 592-599.
6. Peer, D.; Karp, J.M.; Hong, S.; Farokhzad, O.C.; Margalit, R.; Langer, R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751-760.
7. Huynh, N.T.; Passirani, C.; Saulnier, P.; Benoit, J.P. Lipid nanocapsules: A new platform for nanomedicine. Int. J. Pharm. 2009, 379, 201-209.
8. Prego, C.; Torres, D.; Fernandez-Megia, E.; Novoa-Carballal, R.; Quiñoá, E.; Alonso, M.J. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery: Effect of chitosan pegylation degree. J. Control. Release 2006, 111, 299-308.
9. Lozano, M.V.; Torrecilla, D.; Torres, D.; Vidal, A.; Dominguez, F.; Alonso, M.J. Highly efficient system to deliver taxanes into tumor cells: Docetaxel-loaded chitosan oligomer colloidal carriers. Biomacromolecules 2008, 9, 2186-2193.
10. Beduneau, A.; Saulnier, P.; Benoit, J.P. Active targeting of brain tumors using nanocarriers. Biomaterials 2007, 28, 4947-4967.
11. Khalid, M.N.; Simard, P.; Hoarau, D.; Dragomir, A.; Leroux, J.C. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm. Res. 2006, 23, 752-758.
12. Gaucher, G.; Marchessault, R.H.; Leroux, J.C. Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes. J. Control. Release 2010, 143, 2-12.
13. Abdel-Mottaleb, M.M.A.; Neumann, D.; Lamprecht, A. Lipid nanocapsules for dermal application: A comparative study of lipid-based versus polymer-based nanocarriers. Int. J. Pharm. 2011, 79, 36-42.
14. Haley, B.; Frenkel, E. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol. 2008, 26, 57-64.
15. Mailänder, V.; Landfester, K. Interaction of nanoparticles with cells. Biomacromolecules 2009, 10, 2379-2400.
16. Mohanraj, V.J.; Chen, Y. Nanoparticles-A review. Trop. J. Pharm. Res. 2006, 5, 561-573.
17. Lee, S.H.; Choi, S.H.; Kim, S.H.; Park, T.G. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: Swelling induced physical disruption of endosome by cold shock. J. Control. Release 2008, 125, 25-32.
18. Santander-Ortega, M.J.; Lozano-Lopez, M.V.; Bastos-Gonzalez, D.; Peula-Garcia, J.M.; Ortega-Vinuesa, J.L. Novel core-shell lipid-chitosan and lipid-poloxamer nanocapsules: Stability by hydration forces. Colloid Polym. Sci. 2010, 288, 159-172.
19. Santander-Ortega, M.J.; Peula-García, J.M.; Goycoolea, F.M.; Ortega-Vinuesa, J.L. Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability. Colloid Surf. B 2011, 82, 571-580.
20. Mosqueira, V.C.F.; Philippe, L.; Barratt, G. Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine. J. Nanosci. Nanotechnol. 2006, 6, 3193-3202.
21. Kwon, G.S.; Okano, T. Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev. 1996, 21, 107-116.
22. Goutayer, M.; Dufort, S.; Josserand, V.; Royère, A.; Heinrich, E.; Vinet, F.; Bibette, J.; Coll, J.; Texier, I. Tumor targeting of functionalized lipid nanoparticles: Assessment by in vivo fluorescence imaging. Eur. J. Pharm. Biopharm. 2010, 75, 137-147.
23. Ambrousi, A.; Gelperina, S.; Khalansky, A.; Tanski, S.; Theisen, A.; Kreuter, J. Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. J. Microencapsul. 2006, 23, 582-592.
24. Torchilin, V.P. Multifunctional nanocarriers. Avd. Drug Deliv. Rev. 2006, 58, 1532-1555.
25. Beduneau, A.; Saulnier, P.; Hindré, F.; Clavreul, A.; Leroux, J.C.; Benoit, J.P. Active targeting of brain tumors using nanocarriers. Biomaterials 2007, 28, 4978-4967.
26. Rata-Aguilar, A.; Sánchez-Moreno, P.; Jódar-Reyes, A.B.; Martín-Rodríguez, A.; Boulaiz, H.; Marchal-Corrales, J.A.; Peula-García, J.M.; Ortega-Vinuesa, J.L. Colloidal stability and -in vitro" antitumor targeting ability of lipid nanocapsules coated by folate-chitosan conjugates. J. Bioact. Compat. Polym. 2012, submitted for publication.
27. Ortega-Vinuesa, J.L.; Hidalgo-Alvarez, R.; de las Nieves, F.J.; Davey, C.; Newman, D.J.; Price, C.P. Characterization of immunoglobulin G bound to latex particles using surface plasmon resonance and electrophoretic mobility. J. Colloid Interface Sci. 1998, 204, 300-311.
28. Ortega-Vinuesa, J.L.; Bastos-González, D. A review of factors affecting the performances of latex agglutination tests. J. Biomater. Sci. Polym. Ed. 2001, 12, 379-408.
29. Gupta, A.K.; Curtis, A.S.G. Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors. Biomaterials 2004, 25, 3029-3040.
30. Zhang, K.; Rossin, R.; Hagooly, A.; Chen, Z.; Welch, M.J.; Wooley, K.L. Folate-mediated cell uptake of shell-cross linked spheres and cylinders. J. Polym. Sci. Part A Polym. Chem. 2008, 46, 7578-7583.
31. Desai, M.P.; Labhasetwar, V.; Walter, E.; Levy, R.J.; Amidon, G.L. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm. Res. 1997, 14, 1568-1573.
32. Panyam, J.; Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 2003, 55, 329-347.
33. Martin, A.; Puig, J.; Galisteo, F.; Serra, J.; Hidalgo-Alvarez, R. On some aspects of the adsorption of immunoglobulin-G molecules on polystyrene microspheres. J. Dispersion Sci. Technol. 1992, 13, 399-416.
34. Koning, G.A.; Morselt, H.W.M.; Scherphof, G.L.; Kamps, J.A.A.M.; Gorter, A.; Allen, T.M. Interaction of differently designed immunoliposomes with colon cancer and Kupffer cells. An in vitro comparison. Pharm. Res. 2003, 20, 1249-1257.
35. Torcello-Gómez, A.; Santander-Ortega, M.J.; Peula-García, J.M.; Maldonado-Valderrama, J.; Gálvez-Ruiz, M.J.; Ortega-Vinuesa, J.L.; Martín-Rodríguez, A. Adsorption of antibody onto Pluronic F68-covered nanoparticles: Link with surface properties. Soft Matter 2011, 7, 8450-8461.
36. Couvreur, P.; Barratt, G.; Fattal, E.; Legrand, P.; Vauthier, C. Nanocapsule technology: A review. Crit. Rev. Ther. Drug Carr. Syst. 2002, 19, 99-134.
37. Peula, J.M.; Santos, R.; Forcada, J.; Hidalgo-Álvarez, R.; de las Nieves, F.J. Study on the colloidal stability mechanisms of acetal-functionalized latexes. Langmuir 1998, 14, 6377-6384.
38. Santander-Ortega, M.J.; Jódar-Reyes, A.B.; Csaba, N.; Bastos-González, D.; Ortega-Vinuesa, J.L. Colloidal stability of Pluronic F68-coated PLGA nanoparticles: A variety of stabilization mechanism. J. Colloid Interface Sci. 2006, 302, 522-529.
39. López-León, T.; Carvalho, E.L.S.; Seijo, B.; Ortega-Vinuesa, J.L.; Bastos-González, D. Physicochemical characterization of chitosan nanoparticles: Electrokinetic and stability behaviour. J. Colloid Interface Sci. 2005, 283, 344-351.
40. Peula, J.M.; Hidalgo-Alvarez, R.; de las Nieves, F.J. Covalent binding of proteins to acetal-functionalized latexes. I. Physics and chemical adsorption and electrokinetic characterization. J. Colloid Interface Sci. 1998, 201, 132-138.
41. Peula, J.M.; Hidalgo-Alvarez, R.; de las Nieves, F.J. Coadsorption of IgG and BSA onto sulfonated polystyrene latex: Sequential and competitive coadsorption isotherms. J. Biomater. Sci. Polym. Ed. 1995, 7, 231-240.
42. Ortega-Vinuesa, J.L.; Galvez-Ruiz, M.J.; Hidalgo-Alvarez, R. F(ab')2-Coated polymer carriers: Electrokinetic behavior and colloid stability. Langmuir 1996, 12, 3211-3220.
43. Molina-Bolívar, J.A.; Galisteo-González, F.; Hidalgo-Álvarez, R. The role played by hydration forces in the stability of protein-coated particles: Non-classical DLVO behaviour. Colloids Surf. B 1999, 14, 3-17.
44. Molina-Bolívar, J.A.; Ortega-Vinuesa, J.L. How proteins stabilize colloidal particles by means of hydration forces. Langmuir 1999, 15, 2644-2653.
45. Peula, J.M.; Hidalgo-Alvarez, R.; de las Nieves, F.J. Covalent binding of proteins to acetal-functionalized latexes. II. Colloidal Stability and Immunoreactivity. J. Colloid Interface Sci. 1998, 201, 139-145.
46. Greenspan, P.; Fowle, S.D. Spectrofluorometric studies of the lipid probe nile red. J. Lipid Res. 1985, 26, 781-789.
47. Florence, A.T.; Hussain, N. Transcytosis of nanoparticle and dendrimer delivery systems: Evolving vistas. Adv. Drug Deliv. Rev. 2001, 50, 69-89.
48. Hafner, A.; Lovric, J.; Voinovich, D.; Filipovic-Grcic, J. Melatonin-loaded lecithin/chitosan nanoparticles: Physicochemical characterization and permeability through Caco-2 cell monolayers. Int. J. Pharm. 2009, 381, 205-213.
49. Vonarbourg, A.; Passirani, C.; Saulnier, P.; Benoit, J.P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006, 27, 4356-4373.
50. Prego, C.; Fabre, M.; Torres, D.; Alonso, M.J. Efficacy and mechanims of action of chitosan nanocapsules for oral peptide delivery. Pharm. Res. 2006, 23, 549-556.
51. Wulff-Pérez, M.; Torcello-Gómez, A.; Gálvez-Ruíz, M.J.; Martín-Rodríguez, A. Stability of emulsions for parenteral feeding: Preparation and characterization of o/w nanoemulsions with natural oils and pluronic F68 as surfactant. Food Hydrocolloids 2009, 23, 1096-1102.
52. Peula-García, J.M.; Ortega-Vinuesa, J.L.; Bastos-González, D. Inversion of Hofmeister series by chanching the surface of colloidal particles from hydrophobic to hydrophilic. J. Phys. Chem. 2010, 114, 11133-11139.
53. BD CellQuest Pro software, version 3.3; Becton, Dickinson and Company: San Jose, CA, USA, 2002.
54. SPSS, version 7.5; statistical package for the social sciences; IBM Corporation: Chicago, IL, USA, 1997.